Botanix Pharmaceuticals Limited (AU:BOT) has released an update.
Botanix Pharmaceuticals Limited is gearing up for the Q4 2024 launch of their new product, Sofdra™ gel, by strengthening their team with key hires in sales, marketing, and operations. The company has also renewed the contract of Executive Chairman Vince Ippolito with an increased base salary and incentive plan. Additionally, Botanix has announced its Annual General Meeting, set for November 4, 2024, in Perth, Western Australia.
For further insights into AU:BOT stock, check out TipRanks’ Stock Analysis page.
